TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aspergillosis
Investigators at Fudan University target aspergillosis
September 30th, 2008
"Invasive pulmonary aspergillosis (IPA) is a rapid, progressive, fatal disease that occurs mostly in immunocompromised patients. Patients with severe liver disease are at a heightened risk for infections," researchers in Shanghai, People's Republic of China report. "Little is known about the clinical presentation including predisposing factors and treatment of IPA in patients with hepatic failure. Medical records of patients with hepatic failure between November 2005 and February 2007 were reviewed for lung infection. Nine medical records of definitive diagnosis of IPA and three of probable IPA were identified. The main predisposing factors were found to be prolonged...
Source: TB & Outbreaks Week (2008-09-30)
|
